Topic: Paediatric diabetes
Document Owner: Clinical design and innovation
National Group: National clinical programme paediatric diabetes
Effective From: 01 October 2020
Unfortunately, you are using an outdated browser. Please, upgrade your browser to improve your experience with HSE. The list of supported browsers:
The purpose of this guideline is to provide a framework for the utilisation of CGM and Flash GM in children and young people under the care of the paediatric diabetes services. These guidelines are intended for healthcare professionals, particularly those in training, who are working in HSE-funded paediatric and neonatal services. This policy applies to clinical staff in the diabetes team and sets out the process to be followed for use in managing CGM or Flash GM for all children